Primary graft dysfunction after lung transplantation;Disfunción primaria del injerto tras el trasplante pulmonar

Medicina Intensiva

Volumn 36, Issue 7, 2012, Pages 506-512

  Suarez Lopez V J ^a   Minambres E ^a   Robles Arista, J C ^b   Ballesteros, M A ^a  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^b HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

Author keywords

Bronchiolitis obliterans syndrome; Lung transplantation; Primary graft dysfunction

Indexed keywords

LUNG SURFACTANT; NITRIC OXIDE;

ACUTE LUNG INJURY; ARTICLE; ARTIFICIAL VENTILATION; BRONCHIOLITIS OBLITERANS; LUNG PARENCHYMA; LUNG TRANSPLANTATION; MORBIDITY; MORTALITY; NONCARDIOGENIC LUNG EDEMA; OXYGENATION; POSTOPERATIVE PERIOD; PRIMARY GRAFT DYSFUNCTION; REPERFUSION INJURY; RISK FACTOR;

HUMANS; LUNG TRANSPLANTATION; PRIMARY GRAFT DYSFUNCTION; PROGNOSIS; RISK FACTORS;

EID: 84865975961     PISSN: 02105691     EISSN: 15786749     Source Type: Journal    
DOI: 10.1016/j.medin.2012.03.017     Document Type: Article

References (45)

1. Lee J.C., Christie J.D., Keshavjee S. Primary graft dysfuntion: definition, risk, factors, short-and long-term outcomes. Semin Respir Crit Care Med 2010, 31:161-171.
2. Fiser S.M., Tribble C.G., Long S.M., Kaza A.K., Kern J.A., Jones D.R., et al. Ischemia-reperfusion injury after lung transplantation increases risk of late bronchiolitis obliterans syndrome. Ann Thorac Surg 2002, 73:1041-1047.
3. Daud S.A., Yusen R.D., Meyers B.F., Chakinala M.M., Walter M.J., Aloush A.A., et al. Impact of inmediate primary lung allograft dysfunction on bronchiolitis obliterans syndrome. Am J Respir Crit Care Med 2007, 175:507-513.
4. Burton C.M., Iversen M., Milman N., Zemtsovski M., Carlsen J., Steinbrüchel D., et al. Outcome of lung transplanted patients with primary graft dysfunction. Eur J Cardiothorac Surg 2007, 31:75-82.
5. Khan S.U., Salloum J., O'Donovan P.B., Mascha E.J., Mehta A.C., Matthay M.A., et al. Acute pulmonary edema after lung transplantation: the pulmonary reimplantation response. Chest 1999, 116:187-194.
6. Christie J.D., Bavaria J.E., Palevsky H.I., Litzky L., Blumenthal N.P., Kaiser L.R., et al. Primary graft failure following lung transplantion. Chest 1998, 114:51-60.
7. Christie J.D., Sager J.S., Kimmel S.E., Ahya V.N., Gaughan C., Blumenthal N.P., et al. Impact of primary graft failure on outcomes following lung transplantation. Chest 2005, 127:161-165.
8. Christie J.D., Kotloff R.M., Pochettino A., Arcasoy S.M., Rosengard B.R., Landis J.R., et al. Clinical risk factors for primary graft failure following lung transplantation. Chest 2003, 124:1232-1241.
9. Chatila W.M., Furukawa S., Gaughan J.P., Criner G.J. Respiratory failure after lung transplantation. Chest 2003, 123:165-173.
10. King R.C., Binns O.A., Rodriguez F., Kanithanon R.C., Daniel T.M., Spotnitz W.D., et al. Reperfusion injury significantly impacts clinical outcome after pulmonary transplantation. Ann Thorac Surg 2000, 69:1681-1685.
11. Thabut G., Vinatier I., Stern J.B., Lesèche G., Loirat P., Fournier M., et al. Primary graft failure following lung transplantation: predictive factors of mortality. Chest 2002, 121:1876-1882.
12. Christie J.D., Carby M., Bag R., Corris P., Hertz M., Weill D. Report of the ISHLT working group on primary lung graft dysfunction: Part II: Definition. A consensus statement of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 2005, 24:1454-1459. ISHLT Working Group on Primary Lung Graft Dysfunction.
13. Arcasoy S.M., Kotkloff R.M. Lung transplantation. N Engl J Med 1999, 340:1081-1091.
14. Christie J.D., Van Raemdonck D., De Perrot M., Barr M., Keshavjee S., Arcasoy S., et al. ISHLT Working Group on Primary Lung Graft Dysfunction part I: introduction and methods. J Heart Lung Transplant 2005, 24:1451-1513.
15. Arcasoy S.M., Fisher A., Hachem R.R., Scavuzzo M., Ware L.B. Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part V: predictors and outcomes. J Heart Lung Tansplant 2005, 24:1483-1488. ISHLT Working Group on Primary Lung Dysfunction.
16. Bharat A., Saini D., Steward N., Hachem R., Trulock E.P., Patterson G.A., et al. Antibodies to self-antigens predispose to primary lung allograft dysfunction and chronic rejection. Ann Thorac Surg 2010, 90:1094-1101.
17. Hadjiliadis D., Chaparro C., Reinsmoen N.L., Gutierrez C., Singer L.G., Steele M.P., et al. Pretransplant panel reactive antibody in lung transplant recipients is associated with significantly worse post-transplant survival in a multicenter study. J Heart Lung Transplant 2005, 24(7 Suppl):S249-S254.
18. Yoshida S., Haque A., Mizobuchi T., Iwata T., Chiyo M., Webb T.J., et al. Anti-type V collagen lymphocytes that express IL-17 and IL-23 induce rejection pathology in fresh and well-healed lung transplants. Am J Transplant 2006, 6:724-735.
19. Kuntz C.L., Hadjiliadis D., Ahya V.N., Kotloff R.M., Pochettino A., Lewis J., et al. Risk factors for early primary graft dysfunction after lung transplantion: a registry study. Clin Transplant 2009, 23:819-830.
20. Lee J.C., Kuntz C.L., Hadjiliadis D., Ahya V.N., Kawut S.M., Wille K., et al. Risk factors for early vs late primary graft dysfunction. Am J Respir Crit Care Med 2008, 177:A396.
21. De Perrot M., Bonser R.S., Dark J., Kelly R.F., McGiffin D., Menza R., et al. Report of the ISHLT working group on primary lung graft dysfunction: Part III. Donor-related risk factors and markers. J Heart Lung Transplant 2005, 24:1460-1467.
22. Whitson B.A., Nath D.S., Johnson A.C., Walker A.R., Prekker M.E., Radosevich D.M., et al. Risk factors for primary graft dysfunction after lung transplantation. J Thorac Cardiovasc Surg 2006, 131:73-80.
23. Covarrubias M., Ware L.B., Kawut S.M., De Andrade J., Milstone A., Weinacker A., et al. Plasma intracellular adhesion molecule-1 and von Willebrand factor in primary graft dysfunction after lung transplantation. Am J Transplant 2007, 7:2573-2578.
24. Iwai A., Sakano T., Uenishi M., Sugimoto H., Yoshioka T., Sugimoto T. Effects of vasopressin and catecholamines on the maintenance of circulatory stability in brain-dead patients. Transplantation 1989, 48:613-617.
25. Chen J.M., Cullinane S., Spanier T.B., Artrip J.H., John R., Edwards N.R., et al. Vasopressin deficiency and pressor hypersensitivity in hemodynamically unstable organ donors. Circulation 1999, 100(Suppl. 19):II244-II246.
26. Washida M., Okamoto R., Manaka D., Yokoyama T., Yamamoto Y., Ino K., et al. Beneficial effect of combined triiodothyronine and vasopressin administration on hepatic energy status and systemic hemodynamics after brain death. Transplantation 1992, 54:44-49.
27. Ware L.B., Fang X., Wang Y., Sakuma T., Hall T.S., Matthay M.A., et al. Selected contribution: mechanisms that may stimulate the resolution of alveolar edema in the transplanted human lung. J Appl Physiol 2002, 93:1869-1874.
28. Miñambres E., González-Castro A., Rabanal J.M., Suberviola B., Ortega F.J., Zurbano F., et al. Comparative study of two preservation solutions in the initial function after bilateral human lung transplantation. Med Intensiva 2007, 31:1-5.
29. Chiang C.H., Wu K., Yu C.P., Yan H.C., Perng W.C., Wu C.P. Hypothermia and prostaglandin E1 produce synergistic attenuation of ischemia-reperfusion lung injury. Am J Respir Crit Care Med 1999, 160:1319-1323.
30. Adatia I., Lillehei C., Arnold J.H., Thompson J.E., Palazzo R., Fackler J.C., et al. Inhaled nitric oxide in the treatment of postoperative graft dysfunction after lung transplantation. Ann Thorac Surg 1994, 57:1311-1318.
31. Date H., Triantafillou A.N., Trulock E.P., Pohl M.S., Cooper J.D., Patterson G.A. Inhaled nitric oxide reduces human allograft dysfunction. J Thorac Cardiovasc Surg 1996, 111:913-919.
32. Macdonald P., Mundy J., Rogers P., Harrison G., Branch J., Glanville A., et al. Successful treatment of life-threatening acute reperfusion injury after lung transplantation with inhaled nitric oxide. J Thorac Cardiovasc Surg 1995, 110:861-863.
33. Shargall Y., Guenther G., Ahya V.N., Ardehali A., Singhal A., Keshavjee S. Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part VI: treatment. J Heart Lung Transplant 2005, 24:1489-1500.
34. Meade M.O., Granton J.T., Matte-Martyn A., McRae K., Weaver B., Cripps P., et al. A randomized trial of inhaled nitric oxide to prevent ischemia-reperfusion injury after lung transplantation. Am J Respir Crit Care Med 2003, 167:1483-1489.
35. Botha P., Jeyakanthan M., Rao J.N., Fisher A.J., Prabhu M., Dark J.H., et al. Inhaled nitric oxide for modulation of ischemia-reperfusion injury in lung transplantation. J Heart Lung Transplant 2007, 26:1199-1205.
36. Fischer S., Bohn D., Rycus P., Pierre A.F., de Perrot M., Waddell T.K., et al. Extracorporeal membrane oxygenation for primary graft dysfunction after lung transplantation: analysis of the Extracorporeal Life Support Organization (ELSO) registry. J Heart Lung Transplant 2007, 26:472-477.
37. Bermudez C.A., Adusumilli P.S., McCurry K.R., Zaldonis D., Crespo M.M., Pilewski J.M., et al. Extracorporeal membrane oxygenation for primary graft dysfunction after lung transplantation: long term survival. Ann Thorac Surg 2009, 87:854-860.
38. Tagawa T., Yamasaki N., Tsuchiya T., Miyazaki T., Hara A., Amenomori M., et al. Inmediate single lobar retransplantation for primary graft dysfunction after living-donor lobar lung transplantation: Report of a case. Surg Today 2011, 41:1447-1449.
39. Arcasoy S.M., Fisher A., Hachem R.R., Scavuzzo M., Ware L.B. Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part V: predictors and outcomes. J Heart Lung Transplant 2005, 24:1483-1488.
40. Prekker M.E., Nath D.S., Walker A.R., Johnson A.C., Hertz M.I., Herrington C.S., et al. Validation of the proposed International Society for Heart and Lung Transplantation grading system for primary graft dysfunction after lung transplantation. J Heart Lung Transplant 2006, 25:371-378.
41. Whitson B.A., Prekker M.E., Herrington C.S., Whelan T.P., Radosevich D.M., Hertz M.I., et al. Primary Graft dysfunction and long-term pulmonary function after lung transplantation. J Heart Lung Transplant 2007, 26:1004-1011.
42. Bharat A., Narayanan K., Street T., Fields R.C., Steward N., Aloush A., et al. Early posttransplant inflammation promotes the development of alloimmunity and chronic human lung allograft rejection. Transplantation 2007, 83:150-158.
43. Miñambres E., Zurbano F., Naranjo S., González-Castro A., Mons R., González-Fernández C., et al. Lung transplantation using donors 55 years and older. Med Intensiva 2011, 35:403-409.
44. De Vleeschauwer S., Van Raemdonck D., Vanaudenaerde B., Vos R., Meers C., Wauters S., et al. Early outcome after lung transplantation from non-heart-beating donors is comparable to heart-beating-donors. J Heart Lung Transplant 2009, 28:380-387.
45. Cypel M., Yeung J.C., Liu M., Anraku M., Chen F., Karolak W., et al. Normothermic ex vivo lung perfusion in clinical lung transplantation. N Engl J Med 2011, 364:1431-1440.